Glycoprotein hormone administered in ug dose. No CYP-interactions recognised..

(To be edited, initial data ST OCT 04) Human erythropoietin with longer half time in the circulation than recombinant hormone, due to higher carbohydrate contents. Parenterally administered in ug quantities in anemia secondary to chronic renal insufficiency.

Uneventful use reported in 2 patients with acute porphyria.